Aurobindo Pharma Limited (Unit I)
Aurobindo Pharma Limited (Unit I) appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0127-2019, Class II) was initiated on October 24, 2018.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0127-2019 | Class II | Irbesartan Bulk Active Pharmaceutical Ingredient. | October 24, 2018 |